Kolkata, West Bengal – B B Eye Foundation, has been one of the pioneering institutions to begin Phacoemulsification and LASIK in Eastern India, home to excellence in eyecare for the last 34 years. Today, for the benefit of our cataract and glaucoma patients we share the introduction of iStent Inject and iStent Inject W technology.
Surgery in Glaucoma
Glaucoma is a disease of the eye where progressive rise in eye pressure leads to loss of vision. It is often called the ‘silent theft of vision’ as it does not present with any symptoms during the early stages of the disease. Micro Invasive Glaucoma Surgery (MIGS), is the latest advancement in the surgical management of glaucoma to reduce the burden of the disease. Patients with glaucoma are often weighed down by multiple drops at specific intervals. Traditionally only patients with uncontrolled eye pressure glaucoma have been advised for glaucoma surgeries. With the iStent technology in the arsenal, patients with mild to moderate glaucoma may be treated with a fifteen minute procedure to allow them to become medication free.
Dr. Chandrima Paul’s performs East India’s first iStent Inject procedure.
Benefits of iStent technology for patients:
- High safety profile compared to older microinvasive glaucoma surgeries
- Minimal postoperative discomfort with quick recovery
- Fewer and less frequent postoperative check ups
- Suitable for patients with early glaucoma
- Lesser impact on quality of life
When you have glaucoma and cataract
Additionally, a boon for this procedure is the ability for surgeons to perform it as a combined procedure for patients with glaucoma undergoing cataract surgery with high safety and efficacy. Patients with early glaucoma on 1-2 anti-glaucoma medications who develop cataract have performed exceedingly well following cataract surgery and iStent implantation, making them medicine free postoperatively.
Dr. Anujeet Paul, implants his first iStent Inject and shares the ease of use of the device.
Expert endorsements
Dr. Chandrima Paul was the first surgeon in Eastern India to implant the iStent Inject in December 2022 and has subsequently incorporated this procedure in her three decade long clinical practice.
Dr. Sumit Chowdhury has also shared his experience with the iStent Inject and mentions that it shows incredible promise for his patients with glaucoma on one or two medications.
Dr. Anujeet Paul who recently implanted the iStent Inject has highlighted its ease of use and high safety profile. He adds that it will be a boon with cataract patients with early glaucoma looking to let go of all medication post surgery.
About B B Eye Foundation
B B Eye Foundation is a 34 year old institution that has been on the forefront of transformational eye care in Eastern India. With the commitment to serve with expertise, technology and humanity, the institution has been the first to revolutionise cataract surgery with phacoemulsification and LASIK surgery with Femto LASIK and Contoura Vision Technology. Today, it is home to Premium Cataract Surgery with Multifocal, Toric and EDOF IOLs, Glaucoma Surgery with MIGS, Vitreoretinal Surgery and MIVS.
Disclaimer: This article is sponsored. The editorial team has independently verified the content, but the sponsor's views and opinions may differ from our own.